These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26769917)

  • 41. Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences.
    King HE; Wakeford A; Taylor W; Wetzell B; Rice KC; Riley AL
    Pharmacol Biochem Behav; 2015 Oct; 137():16-22. PubMed ID: 26216834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain.
    Adám A; Gerecsei LI; Lepesi N; Csillag A
    Neurotoxicology; 2014 Sep; 44():231-6. PubMed ID: 25063209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
    Gregg RA; Rawls SM
    Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF-TrkB pathway.
    Duart-Castells L; López-Arnau R; Vizcaíno S; Camarasa J; Pubill D; Escubedo E
    Biochem Pharmacol; 2019 May; 163():84-93. PubMed ID: 30738029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.
    Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M
    Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.
    Berquist MD; Baker LE
    Behav Pharmacol; 2017 Aug; 28(5):394-400. PubMed ID: 28598863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.
    Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH
    Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood.
    López-Arnau R; Luján MA; Duart-Castells L; Pubill D; Camarasa J; Valverde O; Escubedo E
    Br J Pharmacol; 2017 May; 174(10):1161-1173. PubMed ID: 28262947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
    Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
    Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.
    Colon-Perez LM; Tran K; Thompson K; Pace MC; Blum K; Goldberger BA; Gold MS; Bruijnzeel AW; Setlow B; Febo M
    Neuropsychopharmacology; 2016 Aug; 41(9):2352-65. PubMed ID: 26997298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.
    Bonano JS; Glennon RA; De Felice LJ; Banks ML; Negus SS
    Psychopharmacology (Berl); 2014 Jan; 231(1):199-207. PubMed ID: 23949206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats.
    Shokry IM; Sinha V; Da Silva G; Park SB; Callanan JJ; Tao R
    Exp Neurol; 2019 Mar; 313():26-36. PubMed ID: 30521789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
    Collins GT; Sulima A; Rice KC; France CP
    Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.
    Kolanos R; Solis E; Sakloth F; De Felice LJ; Glennon RA
    ACS Chem Neurosci; 2013 Dec; 4(12):1524-9. PubMed ID: 24116392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.
    Gannon BM; Galindo KI; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2017 Apr; 361(1):181-189. PubMed ID: 28179474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.
    McClenahan SJ; Hambuchen MD; Simecka CM; Gunnell MG; Berquist MD; Owens SM
    Drug Alcohol Depend; 2019 Feb; 195():140-147. PubMed ID: 30634109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.
    Hyatt WS; Berquist MD; Chitre NM; Russell LN; Rice KC; Murnane KS; Fantegrossi WE
    Behav Pharmacol; 2019 Oct; 30(7):555-565. PubMed ID: 31211703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
    Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
    Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.